JENKEM: Actively exploring the optimization of existing R&D processes through AI

Zhitong
2025.09.02 07:36

JENKEM stated on the interactive platform on September 2nd that the company has initially formed and is continuously strengthening its computational biology team to actively explore the optimization of existing R&D processes through AI, particularly in key areas such as drug structure design and molecular screening. The goal is to achieve a more scientific and efficient decision-making process, thereby promoting the R&D progress of polyethylene glycol material innovation applications. As of now, the company has not yet achieved significant R&D results through AI, and it will not have a major impact on the company's performance in the short term. However, the company recognizes the enormous potential of AI technology in enhancing R&D efficiency and reducing R&D costs

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.